Staging Systems and Nomograms for Soft Tissue Sarcoma

Curr Oncol. 2023 Mar 26;30(4):3648-3671. doi: 10.3390/curroncol30040278.

Abstract

Reliable tools for prognosis prediction are crucially needed by oncologists so they can tailor individual treatments. However, the wide spectrum of histologies and prognostic behaviors of sarcomas challenges their development. In this field, nomograms could definitely better account for their granularity compared to the more widely used AJCC/UICC TNM staging system. Nomograms are predictive tools that incorporate multiple risk factors and return a numerical probability of a clinical event. Since the development of the first nomogram in 2002, several other nomograms have been built, either general, site-specific, histology-specific, or both. Recently, some new "dynamic" nomograms and prognostic tools have been developed, allowing doctors to "recalculate" a patient's prognosis by taking into account the time since primary surgery, the event history, and the potential time-dependent effect of covariates. Due to these new tools, prognosis prediction is no longer limited to the time of the first computation but can be adapted and recalculated based on the occurrence (or not) of any event as time passes from the first computation. In this review, we aimed to give an overview of the available nomograms for STS and to help clinicians in the process of selecting the best tool for each patient.

Keywords: nomogram; prognosis; recurrence; sarcoma; survival.

Publication types

  • Review

MeSH terms

  • Humans
  • Neoplasm Staging
  • Nomograms
  • Prognosis
  • Sarcoma* / pathology
  • Soft Tissue Neoplasms*

Grants and funding

This research received no external funding.